Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of olive oil, betaine, and xylitol is a therapeutic oral care composition, often marketed under the name Saliactive, designed to address oral dysbiosis and inflammatory conditions such as gingivitis. Delivered primarily via toothpaste or oral gels, the formulation utilizes the synergistic effects of its three main components to restore eubiosis in the oral microbiome. Olive oil acts as an emollient and barrier protector, containing phenolic compounds with antimicrobial and anti-inflammatory properties. Betaine (trimethylglycine) serves as a humectant and osmoprotectant, helping to hydrate the oral mucosa and protect cells from osmotic stress. Xylitol, a polyol, inhibits the growth of cariogenic bacteria like *Streptococcus mutans* by interfering with their metabolic pathways and helps maintain a neutral pH to prevent enamel demineralization. This combination is being evaluated for its ability to reduce clinical signs of inflammation and restore the balance of the oral ecological net.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on olive oil + betaine + xylitol.